UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 27, 2018

 

MAGNEGAS CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   001-35586   26-0250418

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employee

Identification No.)

 

11885 44th Street North

Clearwater, FL 33762

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (727) 934-3448

 

Not applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]

 

 

 

     
 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Securities Settlement Agreement

 

On June 27, 2018, MagneGas Corporation (the “Company”) entered into a Securities Settlement Agreement (“SSA”) with Maxim Group, LLC (“Maxim”) attached hereto as Exhibit 10.1. Maxim is entitled to certain placement agent fees from the Company in the aggregate amount of $556,016 arising from the consummation of that certain convertible preferred transaction dated as of June 12, 2017, pursuant to that certain engagement letter, dated March 7, 2017, by and between the Company and Maxim. Under the terms of the SSA and at the closing, the Company will issue to Maxim 817,670 shares of Series F Convertible Preferred Stock with an initial total value of $556,016 (“Preferred Stock”).The Preferred Stock has an initial conversion price of $0.68 per share and will be initially convertible into an aggregate of 817,670 shares of Common Stock.

 

Upon execution of the SAA, the Company reduced its outstanding obligations by $556,016.

 

The Company obtained the written consent of the holders of a majority of its outstanding voting securities approving the terms of the SSA and the issuance of the Preferred Stock, including the potential issuance of more than 20% of the Company’s issued and outstanding common stock in connection with the SSA, in accordance with Nasdaq Listing Rule 5635. The Company is also required to file with the Securities and Exchange Commission, and mail to its stockholders, a definitive information statement in compliance with Rule 14c-2 promulgated under the Securities Exchange Act of 1934, as amended.

 

The issuance of the Preferred Stock is being made pursuant to a prospectus supplement and accompanying base prospectus relating to the Company’s effective shelf registration statement on Form S-3 (File No. 333-207928).

 

The above description of the SSA does not purport to be complete and is qualified in its entirety by the full text of such SSA, which is incorporated herein and attached hereto as Exhibit 10.1.

 

A copy of the opinion of our General Counsel relating to the legality of the issuance and sale of the Preferred Stock is attached as Exhibit 5.1 hereto.

 

Leak Out Agreement

 

The sale of the Preferred Stock sold pursuant to the SSA is subject a Leak Out Agreement (“Leak Out Agreement”). The Leak Out Agreement, among other things, limits the amount of the securities that the Holder (as defined in the Leak Out Agreement) can sell or otherwise dispose of or transfer per trading day to no more than 5% of the trading volume of the Company’s common stock as reported by Bloomberg, LP for the applicable Date of Determination (as defined in the Leak Out Agreement).

 

The above description of the Leak Out Agreement does not purport to be complete and is qualified in its entity by the full text of such Leak Out  Agreement, which is incorporated herein and attached hereto as Exhibit 10.2.

 

Series F Convertible Preferred Stock

 

The Company has designated a new class of preferred stock as “Series F Convertible Preferred Stock” in the aggregate amount of 817,670 shares (“Preferred Shares”). The Preferred Shares have a stated value of $0.68, with an aggregate value of $556,016.

 

The initial conversion price of the Preferred Shares is $0.68 per share.

 

The Certificate of Designations includes the right of Alternative Conversion, through which the holder may, at its option and in accordance with the Certificate of Designations, convert any Preferred Shares at an Alternate Conversion Price. The “Alternate Conversion Price” means with respect to any Alternate Conversion that price which shall be the lowest of (A) the applicable Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion and (B) the greater of (x) the Floor Price and (y) the lowest of (i) 75% of the Closing Bid Price of the Common Stock as of the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice, (ii) 75% of the VWAP of the Common Stock as of the Trading Day of the delivery or deemed delivery of the applicable Conversion Notice, (iii) 75% of the sum of the lowest VWAP of the Common Stock for each Trading Day during three (3) out of the ten (10) consecutive Trading Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice, divided by (I) three (3), (iv) 75% of the price computed as the quotient of (I) the sum of the lowest VWAP of the Common Stock for each Trading Day during five (5) of the twenty (20) consecutive Trading Day period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice, divided by (II) five (5).

 

     
 

 

The holders of Preferred Shares shall be entitled to receive dividends, when and as declared by the Board, from time to time, in its sole discretion which dividends shall be paid by the Company out of funds legally available therefor, payable, subject to the conditions and other terms of the Certificate of Designations, in cash on the Stated Value of such Preferred Share.

 

The Company is not permitted issue any shares of Common Stock upon conversion of any Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations if the issuance of such shares of Common Stock would exceed the aggregate number of shares of Common Stock which the Company may issue pursuant to the Securities Settlement Agreement or upon conversion of the Preferred Shares or otherwise pursuant to the respective terms thereof without breaching the Company’s obligations under the rules or regulations of the Principal Market (the number of shares which may be issued without violating such rules and regulations, the “Exchange Cap”), except that such limitation shall not apply in the event that the Company (A) obtains the approval of its stockholders as required by the applicable rules of the Principal Market for issuances of shares of Common Stock in excess of such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall be reasonably satisfactory to the Required Holders. Until such approval or such written opinion is obtained, no Holder shall be issued in the aggregate, upon conversion of any Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations, shares of Common Stock in an amount greater than the product of (i) the Exchange Cap as of the Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of Preferred Shares issued to such Holder pursuant to the Securities Settlement Agreement on the Closing Date divided by (2) the aggregate number of Preferred Shares issued to the Holders pursuant to the Securities Settlement Agreement on the Closing Date (with respect to each Buyer, the “Exchange Cap Allocation”). In the event that any Holder shall sell or otherwise transfer any of such Holder’s Preferred Shares, the transferee shall be allocated a pro rata portion of such Holder’s Exchange Cap Allocation with respect to such portion of such Preferred Shares so transferred, and the restrictions of the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such transferee. Upon conversion and exercise in full of a holder’s Preferred Shares, the difference (if any) between such holder’s Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon such holder’s conversion in full of such Preferred Shares shall be allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares on a pro rata basis in proportion to the shares of Common Stock underlying the Preferred Shares then held by each such holder of Preferred Shares. At any time commencing on the 40th day following the date that the Company is prohibited from issuing any shares of Common Stock as stated above to a Holder, the Holder shall have the right to cause the Company to redeem any Preferred Shares held by the Holder that are not convertible hereunder at a price equal to the Stated Value per redeemed share (or fraction thereof for partial shares). Such cash payment shall be made within five (5) Business Days of demand thereof by the Holder to the Company.

 

The above description of the Certificate of Designations does not purport to be complete and is qualified in its entirety by the full text of such Certificate of Designations, which is incorporated herein and attached hereto as Exhibit 3.1.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

In connection with the SSA, prior to the closing date of the transaction described in Item 1.01 of this Current Report on Form 8-K, the Company filed a Certificate of Designations of Series F Convertible Preferred Stock (the “Certificate of Designations”) with the Secretary of State for the State of Delaware. The Certificate of Designations designated a new class of preferred stock as “Series F Convertible Preferred Stock” in the aggregate amount of 817,670 shares. The Series F Convertible Preferred Stock has a stated value of $0.68 per share of Series F Convertible Preferred Stock and an initial conversion price equal to $0.68 per share. The summary of the rights, powers, and preferences of the Series F Convertible Preferred Stock set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.03.

 

A copy of the Certificate of Designations is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

Item 8.01 Other Events.

 

On June 28, 2018, the Company announced the transaction.

 

A copy of the press release that discusses this matter is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

No.

  Description
     

3.1

 

Certificate of Designations for Series F Convertible Preferred Stock

5.1   Opinion of General Counsel

10.1

 

Securities Settlement Agreement dated June 27, 2018, between the Company and Maxim Group, LLC

10.2   Leak Out Agreement
23.1   Consent of General Counsel (contained in Exhibit 5.1)
99.1   Press Release, dated June 28, 2018, issued by MagneGas Corporation

 

     
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 28, 2018

 

  MAGNEGAS CORPORATION
   
  /s/ Ermanno Santilli
  By: Ermanno Santilli
  Its: Chief Executive Officer

 

     
 

 

 

Exhibit 3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 5.1

 

 

June 27, 2018

 

MagneGas Corporation

11885 44th Street North

Clearwater, Florida 33762

 

Re: Securities Registered under Registration Statement on Form S-3

 

Ladies and Gentlemen:

 

Reference is made herein to the Registration Statement on Form S-3 (File No. 333-207928) (as amended or supplemented, the “Registration Statement”) filed on November 10, 2015 with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), relating to the registration of the offer by MagneGas Corporation, a Delaware corporation (the “Company”), of up to $50,000,000 of any combination of securities of the types specified therein, that was declared effective by the Commission on June 15, 2016. I am delivering this opinion letter in connection with the prospectus supplement (the “Prospectus Supplement”) dated June 27, 2017 to be filed by the Company with the Commission pursuant to Rule 424 under the Securities Act. The Prospectus Supplement relates to the offering by the Company of up to 817,670 shares (the “Shares”) of the Company’s Series F Convertible Preferred Stock, $0.001 par value per share (the “Series F Convertible Preferred Stock”) covered by the Registration Statement. I understand that the Shares are to be offered and sold in the manner described in the Prospectus Supplement.

 

I have reviewed such documents and made such examination of law as I have deemed appropriate to give the opinions set forth below. I have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of the Company.

 

Based on the foregoing, I am of the opinion that:

 

1. The Shares have been duly authorized and, upon issuance and delivery against payment therefor in accordance with the terms of the Securities Settlement Agreement dated as of June 27, 2018 among the Company and Maxim Group, LLC (the “Securities Settlement Agreement”), the Shares will be validly issued, fully paid and non-assessable.

 

2. The Company’s common stock, par value $0.001 per share, issuable upon conversion of the Series F Convertible Preferred Stock, when issued upon conversion of the Series E Convertible Preferred Stock in accordance with the terms of the Certificate of Designation of Rights, Preferences and Privileges of Series F Convertible Preferred Stock, will be validly issued, fully paid and non-assessable.

 

I express no opinion as to the validity, binding effect or enforceability of any provision in the Securities Settlement Agreement to the extent it relates to the choice of forum for resolving disputes.

 

I hereby consent to the filing by you of this opinion as Exhibit 5.1 to the Company’s Current Report on Form 8-K and to the references to our firm under the caption “Legal Matters” in the Prospectus Supplement. In giving my consent, I do not admit that I am in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

 

Very truly yours,

 

/s/ Tyler B. Wilson, Esq.

 

General Counsel

MagneGas Corporation

 

     
 

 

 

SECURITIES SETTLEMENT AGREEMENT

 

This SECURITIES SETTLEMENT AGREEMENT (the “ Agreement ”), dated as of June 27, 2018, is by and among MagneGas Corporation, a Delaware corporation with offices located at 11885 44th St. N. Clearwater, FL 33762 (the “ Company ”) and Maxim Group, LLC (“ Maxim ”).

 

RECITALS

 

  A. Maxim is entitled to certain placement agent fees from the Company in the aggregate amount of $556,016 (the “ Agency Fee ”) arising from the consummation of that certain convertible preferred transaction dated as of June 12, 2017 of the Company, pursuant to that certain engagement letter by and between the Company and Maxim (“ Engagement Agreement ”).
     
  B. The Company and Maxim desire to enter into this transaction for the Company to issue to Maxim 817,670 shares of Preferred Stock (as defined below) in satisfaction and payment in full of payment of the Agency Fee.
     
  C. The issuance of the shares of the Preferred Stock is being made pursuant to a currently effective shelf registration statement on Form S-3, which includes the Preferred Stock registered thereunder (Registration Number 333-207928) (the “ Registration Statement ”), which Registration Statement has been declared effective in accordance with the Securities Act of 1933, as amended (the “ 1933 Act ”), by the United States Securities and Exchange Commission (the “ SEC ”).
     
  D. The Company has authorized a new series of convertible preferred stock of the Company designated as “Series F Convertible Preferred Stock”, $0.001 par value, the terms of which are set forth in the certificate of designation for such series of Preferred Stock (the “ Certificate of Designations ”) in the form attached hereto as Exhibit A (together with any convertible preferred shares issued in replacement thereof in accordance with the terms thereof, the “ Preferred Stock ”), which Preferred Stock shall be convertible into shares of the Company’s common stock (“ Common Stock ”) (such shares of Common Stock issuable pursuant to the terms of the Certificate of Designations, including, without limitation, upon conversion or otherwise, collectively, the “ Conversion Shares ”), in accordance with the terms of the Certificate of Designations.
     
  E. The Preferred Stock and the Conversion Shares are collectively referred to herein as the “ Securities ”.

 

 
 

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the recitals above incorporated herein by this reference and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Maxim hereby agree as follows:

 

1. ISSUANCE OF PREFERRED STOCK IN SATISFACTION OF AGENCY FEE.

 

(a) Issuance of Preferred Stock. In satisfaction in full of the payment of the Agency Fee to Maxim, the Company shall issue to Maxim on the Closing Date (as defined below) 817,670 shares of Preferred Stock.

 

(b) Closing. The closing (the “ Closing ”) of the purchase of the Preferred Stock by Maxim shall occur at the offices of Ellenoff Grossman & Schole LLP. The date and time of the Closing (the “ Closing Date ”) shall be 10:00 a.m., New York time, on the first (1st) Business Day (as defined below) after the date hereof. As used herein “ Business Day ” means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to remain closed.

 

2. MAXIM’S REPRESENTATIONS AND WARRANTIES.

 

Maxim represents and warrants to the Company with respect to only itself that, as of the date hereof and as of the Closing Date:

 

(a) Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of Maxim and shall constitute the legal, valid and binding obligations of Maxim enforceable against Maxim in accordance with its respective terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies. 

 

(b) No Conflicts. The execution, delivery and performance by Maxim of this Agreement and the consummation by Maxim of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of Maxim, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which Maxim is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to Maxim, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of Maxim to perform its obligations hereunder. 

 

3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The Company represents and warrants to Maxim that, as of the date hereof and as of the Closing Date:

 

2
 

 

(a) Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its obligations under this Agreement and to issue the Securities in accordance with the terms hereof and thereof. The execution and delivery of this Agreement by the Company, and the consummation by the Company of the transactions contemplated hereby (including, without limitation, the issuance of the shares of Preferred Stock and the reservation for issuance of the Conversion Shares issuable upon conversion of the shares of Preferred Stock) have been duly authorized by the Company’s board of directors and (other than (x) the filing with the SEC of the prospectus supplement related to the Securities required by Rule 424(b) under the 1933 Act (the “ Prospectus Supplement ”) supplementing the base prospectus forming part of the Registration Statement (such base prospectus as so supplemented, the “ Prospectus ”) and (y) any other filings as may be required by any state securities agencies (collectively, the “ Required Filings” )) no further filing, consent or authorization is required by the Company, its subsidiaries, their respective boards of directors or their stockholders or other governing body. This Agreement has been duly executed and delivered by the Company, and constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. The Certificate of Designations in the form attached hereto as Exhibit A will be filed with the Delaware Secretary of State and will be in full force and effect as of the Closing, enforceable against the Company in accordance with its terms and will not have been amended as of the Closing.

 

(b) Issuance of Securities. The issuance of the shares of Preferred Stock is duly authorized and shall be validly issued, fully paid and non-assessable and free from all preemptive or similar rights, mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively “ Liens ”) with respect to the issuance thereof. As of the Closing, the Company shall have reserved from its duly authorized capital stock not less than the sum of 100% of the maximum number of Conversion Shares issuable upon conversion of the shares of Preferred Stock as of the date hereof, and any such conversion shall not take into account any limitations on the conversion of the Preferred Stock set forth in the Certificate of Designations). Upon issuance or conversion in accordance with the Preferred Stock, the Conversion Shares, when issued, will be validly issued, fully paid and non-assessable and free from all preemptive or similar rights or liens with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. The issuance of the shares of Preferred Stock and Conversion Shares has been registered under the 1933 Act and are being issued pursuant to the Registration Statement and as such are freely transferable and freely tradable by Maxim without restriction, whether by way of registration or some exemption therefrom. The Registration Statement is effective and available for the issuance of the Securities thereunder and the Company has not received any notice that the SEC has issued or intends to issue a stop-order with respect to the Registration Statement or that the SEC otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, or intends or has threatened in writing to do so. The Registration Statement and any prospectus included therein, including the Prospectus, complied in all material respects with the requirements of the 1933 Act, and the documents incorporated by reference into the Registration Statement when filed, complied in all material respects with the requirements of the 1934 Act and, in each case, with the rules and regulations of the SEC promulgated under the 1933 Act or the 1934 Act, as the case may be. At the time the Registration Statement and any amendments thereto became effective the Registration Statement and any amendments thereto complied with and, upon the filing of the Prospectus Supplement after the date of this Agreement the Registration Statement, will comply in all material respects with the requirements of the 1933 Act and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. The Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and the Prospectus Supplement at the Closing Date, complied and will comply, as the case may be, in all material respects with the requirements of the 1933 Act and did not, and will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The Company meets all of the requirements of General Instruction I.B.6 for the use of Form S-3 under the 1933 Act for the offering and sale of the Securities contemplated by this Agreement, and the SEC has not notified the Company of any objection to the use of the form of the Registration Statement pursuant to Rule 401(g)(1) under the 1933 Act. The Registration Statement meets the requirements set forth in Rule 415(a)(1)(x) under the 1933 Act.

 

3
 

 

(c) No Conflicts. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the transactions contemplated hereby (including, without limitation, the issuance of the shares of Preferred Stock and issuance of the Conversion Shares issuable upon conversion of the shares of Preferred Stock) will not (i) result in a violation of the Certificate of Incorporation (as defined below) (including, without limitation, any certificate of designation contained therein), Bylaws (as defined below), certificate of formation, memorandum of association, articles of association, bylaws or other organizational documents of the Company or any of its subsidiaries, or any capital stock or other securities of the Company or any of its subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including, without limitation, foreign, federal and state securities laws and regulations and the rules and regulations of the Nasdaq Capital Market (the “Principal Market ”) and including all applicable foreign, federal and state laws, rules and regulations) applicable to the Company or any of its subsidiaries or by which any property or asset of the Company or any of its subsidiaries is bound or affected. 

 

(d) Affirmation of Prior Reps and Warranties . The Company represents and warrants that the applicable representations and warranties made by the Company pursuant to that certain placement agency agreement, dated March 7, 2017, remain true and correct as of the date hereof.

 

4. COVENANTS.

 

(a) Listing. The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Conversion Shares upon each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed or designated for quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation for quotation (as the case may be) of all Conversion Shares from time to time issuable under the terms of this Agreement on such national securities exchange or automated quotation system.

 

4
 

 

(b) Pledge of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees that the Securities may be pledged by an Investor in connection with a bona fide margin agreement or other loan or financing arrangement that is secured by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder, and no Investor effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement. The Company hereby agrees to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee by an Investor. 

 

(c) Reservation of Shares. So long as any of the shares of Preferred Stock remain outstanding, the Company shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance, no less than the sum of 100% of the maximum number of shares of Common Stock issuable upon conversion of all the shares of Preferred Stock then outstanding (assuming for purposes hereof that all of the shares of Preferred Stock have been exercised in full, (y) the shares of Preferred Stock are convertible at a conversion price equal to the Alternate Conversion Price (as defined in the Certificate of Designations), and (z) any such conversion shall not take into account any limitations on the conversion of the shares of Preferred Stock set forth in the Certificate of Designations). 

 

(d) Conversion and Exercise Procedures . The form of Conversion Notice (as defined in the Certificate of Designations) included in the Certificate of Designations set forth the totality of the procedures required of Maxim in order to convert the Preferred Stock into shares of Common Stock. No legal opinion, other information or instructions shall be required of Maxim to convert their Preferred Shares, respectively. The Company shall honor conversions of the Preferred Shares and shall deliver the Conversion Shares in accordance with the terms, conditions and time periods set forth in the Certificate of Designations.

 

(e) Regulation M. The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution of the Securities contemplated hereby. 

 

5. REGISTER; TRANSFER AGENT INSTRUCTIONS; LEGEND.

 

(a) Register. The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice to each holder of Securities), a register for the shares of Preferred Stock and Conversion Shares in which the Company shall record the name and address of the person in whose name the shares of Preferred Stock and Conversion Shares have been issued (including the name and address of each transferee), the aggregate number of shares of Preferred Stock and the number of Conversion Shares issuable pursuant to the terms of the Certificate of Designations with respect to the shares of Preferred Stock held by such Person. The Company shall keep the register open and available at all times during business hours for inspection of any Maxim or its legal representatives. 

 

5
 

 

(b) Transfer Agent Instructions. The Company shall issue irrevocable instructions to its Transfer Agent and any subsequent transfer agent in a form acceptable to Maxim (the “ Irrevocable Transfer Agent Instructions ”) to issue certificates or credit shares to the applicable balance accounts at DTC, registered in the name of Maxim or its respective nominee(s), for the (i) shares of Preferred Stock; and (ii) Conversion Shares in such amounts as specified from time to time by Maxim to the Company upon conversion of the Preferred Stock into shares of Common Stock. The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(b) will be given by the Company to its transfer agent with respect to the Securities, and that the Securities shall otherwise be freely transferable on the books and records of the Company, as applicable, to the extent provided in this Agreement. If Maxim effects a sale, assignment or transfer of the Conversion Shares, the Company shall permit the transfer and shall promptly instruct its transfer agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and in such denominations as specified by Maxim to effect such sale, transfer or assignment. All Securities shall be issued without any restrictive legend in accordance with Section 5(c) below. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to Maxim. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5(b) will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section 5(b), that Maxim shall be entitled, in addition to all other available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any bond or other security being required. The Company shall cause its counsel to issue the legal opinion referred to in the Irrevocable Transfer Agent Instructions to the Company’s transfer agent upon each conversion of shares of the Preferred Stock (unless such issuance covered by a prior legal opinion previously delivered to the Transfer Agent), and (ii) on each date a registration statement with respect to the issuance or resale of any of the Securities is declared effective by the SEC. Any fees (with respect to the transfer agent, counsel to the Company or otherwise) associated with the issuance of such opinion or the removal of any legends on any of the Securities shall be borne by the Company. 

 

(c) Legends. Certificates and any other instruments evidencing the Securities shall not bear any restrictive or other legend.

 

(d) FAST Compliance . While any shares of Preferred Stock remain outstanding, the Company shall maintain a transfer agent that participates in the DTC Fast Automated Securities Transfer Program.

 

6. MISCELLANEOUS.

 

(a) Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude Maxim from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company’s obligations to Maxim or to enforce a judgment or other court ruling in favor of Maxim. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, OR ANY TRANSACTION CONTEMPLATED HEREBY.  

 

6
 

 

(b) Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof. 

 

(c) Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found. 

 

(d) Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s). 

 

(e) Entire Agreement; Amendments. Except as set forth in Section 3(d) hereof, this Agreement supersedes all other prior oral or written agreements between Maxim and the Company contains the entire understanding of the parties solely with respect to the matters covered herein. For clarification purposes, the Recitals are part of this Agreement and the Engagement Agreement remains in full force and effect. No provision of this Agreement may be amended or waived other than by an instrument in writing signed by the Company and Maxim. 

 

7
 

 

(f) Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party) or electronic mail; or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly addressed to the party to receive the same. The addresses, facsimile numbers and e-mail addresses for such communications shall be: 

 

If to the Company:

 

MagneGas Corporation
11885 44th St. N.
Clearwater, FL 33762
Telephone: (727) 934-3448
Facsimile: (727) 290-4941
Attention: Chief Financial Officer
E-Mail: scottmahoney@magnegas.com

 

If to the Transfer Agent:

 

Corporate Stock Transfer, Inc.
3200 Cherry Creek Drive South, #430
Denver, CO 80209
Telephone: (303) 282-4800
Facsimile: (303) 282-5800
Attention: Karen Naughton
E-Mail: knaughton@corporatestock.com

 

If to Maxim:

 

Maxim Group, LLC
405 Lexington Avenue, 2 nd Floor
New York, New York 10174
Attn: James Siegel, General Counsel

 

or to such other address, e-mail address and/or facsimile number and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s facsimile machine or e-mail containing the time, date, recipient facsimile number and, with respect to each facsimile transmission, an image of the first page of such transmission or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

 

8
 

 

(g) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns, including any purchasers of any of shares of Preferred Stock. The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of Maxim. Maxim may assign some or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of the Company, in which event such assignee shall be deemed to be Maxim hereunder with respect to such assigned rights. 

 

(h) No Third Party Beneficiaries . This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than the Indemnitees referred to in Section. 

 

(i) Survival . The representations, warranties, agreements and covenants shall survive the Closing. Maxim shall be responsible only for its own representations, warranties, agreements and covenants hereunder. 

 

(j) Further Assurances . Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby. 

 

(k) Construction . The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock and any other numbers in this Agreement that relate to the Common Stock shall be automatically adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions that occur with respect to the Common Stock after the date of this Agreement. 

 

(l) Remedies . Maxim and in the event of assignment by Maxim of its rights and obligations hereunder, each holder of Securities, shall have all rights and remedies set forth in this Agreement and all rights and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights which such holders have under any law. Any person having any rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes that in the event that it fails to perform, observe, or discharge any or all of its obligations under this Agreement, any remedy at law would inadequate relief to Maxim. The Company therefore agrees that Maxim shall be entitled to specific performance and/or temporary, preliminary and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without posting a bond or other security. The remedies provided in this Agreement shall be cumulative and in addition to all other remedies available under this Agreement, at law or in equity (including a decree of specific performance and/or other injunctive relief). 

 

9
 

 

IN WITNESS WHEREOF, Maxim and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

 

  COMPANY:
     
  MAGNEGAS CORPORATION
     
  By: /s/Ermanno Santilli
  Name: Ermanno Santilli
  Title: Chief Executive Officer

 

10
 

 

IN WITNESS WHEREOF, Maxim and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

 

  MAXIM GROUP, LLC
                    
  By:

/s/ Clifford A. Teller

  Name: Clifford A. Teller
  Title: Executive Managing Director, Head of Investment Banking

 

11
 

 

Exhibit A

Certificate of Designations – Series F Convertible Preferred Stock

 

  12  
 

 

 

LEAK-OUT AGREEMENT

 

This agreement (the “ Leak-Out Agreement ”) is being delivered to you in connection with an understanding by and among MagneGas Corporation, a Delaware corporation (the “ Company ”), and the person or persons named on the signature pages hereto (collectively, the “ Holder ”). Capitalized terms used and not otherwise defined herein that are defined in the Securities Settlement Agreement, dated June 27, 2018 by and between the Company and the Holder (the “ Settlement Agreement ”) shall have the meaning given such terms in such Settlement Agreement.

 

Reference is hereby made to (a) the Settlement Agreement, dated June 27, 2018, by and among the Company and the undersigned, pursuant to which the Company agreed to issue in exchange for the forgiveness of certain indebtedness, Series F Convertible Preferred Stock (“ Preferred Stock ”) convertible into 817,670 shares of Common Stock (the shares underlying the Preferred Stock, the “Conversion Shares” and collectively with the Shares, the “ Securities ”).

 

The Holder agrees solely with the Company that from the date that the undersigned executes the Settlement Agreement (the “ Effective Date ”) and ending on the date the Holder no longer holds any of the Company’s Series F Convertible Preferred Stock (“ Preferred Stock ”) or common stock converted from the Preferred Stock (such period, the “ Restricted Period ”), neither the Holder, nor any Affiliate of such Holder which (x) had or has knowledge of the transactions contemplated by the Settlement Agreement, (y) has or shares discretion relating to such Holder’s investments or trading or information concerning such Holder’s investments, including in respect of the Securities, or (z) is subject to such Holder’s review or input concerning such Affiliate’s investments or trading (together, the “ Holder’s Trading Affiliates ”), collectively, shall sell dispose or otherwise transfer, directly or indirectly, (including, without limitation, any sales, short sales, swaps or any derivative transactions that would be equivalent to any sales or short positions) on any Trading Day during the Restricted Period (any such date, a “ Date of Determination ”), an amount of the Securities more than 5% of the trading volume of Common Stock as reported by Bloomberg, LP for the applicable Date of Determination (“ Leak-Out Percentage ”).

 

Notwithstanding anything herein to the contrary, during the Restricted Period, the Holder may, directly or indirectly, sell or transfer all, or any part, of the Shares or the Conversion Shares (the “ Restricted Securities ”) to any Person (an “ Assignee ”) in a transaction which does not need to be reported on the Nasdaq consolidated tape, without complying with (or otherwise limited by) the restrictions set forth in this Leak-Out Agreement; provided, that as a condition to any such sale or transfer an authorized signatory of the Company and such Assignee duly execute and deliver a leak-out agreement in the form of this Leak-Out Agreement (an “ Assignee Agreement ”, and each such transfer a “ Permitted Transfer ”), provided that the Leak-Out Percentage as to such Assignee and the Leak-Out Percentage of the assignor shall be proportionally adjusted based on the original leak-Out Percentage of the Holder.

 

The Holder further agrees (x) not to transfer any Preferred Stock to any Person without the prior written consent of the Company and (y) to forbear from taking any actions, directly or indirectly, to request, effect or otherwise require the redemption, in whole or in part, for cash of any of the Preferred Stock, to the extent permitted pursuant to the terms of the Certificate of Designations, until the six month anniversary of the date hereof.

 

   
 

 

Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Leak-Out Agreement must be in writing and shall be given in accordance with the terms of the Exchange Agreement.

 

This Leak-Out Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and supersedes all prior negotiations, letters and understandings relating to the subject matter hereof and are fully binding on the parties hereto.

 

This Leak-Out Agreement may be executed simultaneously in any number of counterparts. Each counterpart shall be deemed to be an original, and all such counterparts shall constitute one and the same instrument. This Leak-Out Agreement may be executed and accepted by facsimile or PDF signature and any such signature shall be of the same force and effect as an original signature.

 

The terms of this Leak-Out Agreement shall be binding upon and shall inure to the benefit of each of the parties hereto and their respective successors and assigns and shall not be for the benefit of, or be enforceable by, any other person or entity.

 

This Leak-Out Agreement may not be amended or modified except in writing signed by each of the parties hereto.

 

All questions concerning the construction, validity, enforcement and interpretation of this Leak-Out Agreement shall be governed by the Settlement Agreement.

 

Each party hereto acknowledges that, in view of the uniqueness of the transactions contemplated by this Leak-Out Agreement, the Company may not have an adequate remedy at law for money damages in the event that this Leak-Out Agreement has not been performed in accordance with its terms, and therefore agrees that the Company shall be entitled to seek specific enforcement of the terms hereof in addition to any other remedy it may seek, at law or in equity.

 

Without implication that the contrary would otherwise be true, the Company acknowledges and agrees that this Leak-Out Agreement is a separate agreement that is solely between the Company and the undersigned and not between or among any other person or entity.

 

[signature pages follow]

 

[The remainder of the page is intentionally left blank]

 

   
 

 

  Sincerely,
     
  MAGNEGAS CORPORATION
     
  By:

/s/ Ermanno Santilli

  Name: Ermanno Santilli
  Title: CEO                  

 

   
 

 

Agreed to and Acknowledged:  
   
“HOLDER”  
     
Maxim Group, LLC  
     
By:

/s/ Clifford A. Teller

 
Name: Clifford A. Teller  
Title: Executive Managing Director, Head of Investment Banking  

 

   
 

 

 

 

News Release

 

Investor Contacts:

Tirth Patel

Edison Advisors

T: 646-653-7035

tpatel@edisongroup.com

 

 

MagneGas Completes $556,000 Financing

 

Transaction Completed to Clear Accrued Financing Costs

 

Without Consuming Growth Driven Working Capital

 

TAMPA, FL – JUNE 28, 2018 — MagneGas Corporation (“MagneGas” or the “Company”) (NASDAQ: MNGA) , a leading clean technology company in the renewable resources and environmental solutions industries, announced today that it has completed a $556,000 convertible preferred offering with its investment banking partners to clear accrued financing expenses. The terms of this transaction were disclosed in an 8-k filing dated June 28, 2019.

 

“We are pleased to complete this transaction,” commented Ermanno Santilli, Chief Executive Officer of MagneGas. “We appreciate the flexibility demonstrated by our banking partners during our rapid growth, and their support has been an integral part of our ability to execute on a series of acquisitions to expand our industrial gas footprint across Texas and California in this year. Our growth strategy has resulted in rapid sales growth of over $1.0 million in monthly averaged for the second quarter of 2018.”

 

“This was a very opportunistic, targeted financing designed to clear a sizable liability while preserving our working capital liquidity,” commented Scott Mahoney, Chief Financial Officer. “We remain highly focused on generating improved cash flows, enhancing liquidity, and reducing our liabilities. This transaction enabled us to make meaningful progress on all three of these fronts.”

 

About MagneGas Corporation

 

MagneGas Corporation (MNGA) owns a patented process that converts various renewables and liquid wastes into MagneGas® fuels. These fuels can be used as an alternative to natural gas or for metal cutting. The Company’s testing has shown that its metal cutting fuel “MagneGas2®” is faster, cleaner and more productive than other alternatives on the market. It is also cost effective and safe to use with little changeover costs. The Company currently sells MagneGas2® into the metal working market as a replacement to acetylene.

 

The Company also sells equipment for the sterilization of bio-contaminated liquid waste for various industrial and agricultural markets. In addition, the Company is developing a variety of ancillary uses for MagneGas® fuels utilizing its high flame temperature for co-combustion of hydrocarbon fuels and other advanced applications. For more information on MagneGas, please visit the Company’s website at http://www.MagneGas.com .

 

The Company distributes MagneGas2® through Independent Distributors in the U.S and through its wholly owned distributors, ESSI, Green Arc Supply, Trico Welding Supply and Complete Welding of San Diego. ESSI has 3 locations in Florida, Green Arc 2 locations in Texas and one location in Louisiana, Trico has two locations in northern California, and Complete Welding has one location in southern California. For more information on ESSI, please visit the company’s website at http://www.weldingsupplytampa.com .

 

FORWARD-LOOKING STATEMENTS

 

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

 

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.